VVUS: VIVUS INC. (NASDAQ) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Mkilloran who wrote (20012)	3/23/1999 7:27:00 PM
From: VLAD	Read Replies (1) of 23519

martin, I will bet you that eventually Vivus will have a female SD cream on the market and it probably will eventually become an over the counter med. That's where the real money will be made in the US. A female product doesn't really need a doctor patient relation for its success. If MUSE is used improperly a patient can end up with urethral bleeding or product failure. Fainting and the pain factor will probably be an non issue with an alprostidal topical since it is not being delivered transurethrally. I really don't see a lot of possible problems that would restrict such a product from not eventually becoming an over the counter product.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next